Of Model Hosts and Man: Using Caenorhabditis elegans, Drosophila melanogaster and Galleria mellonella as Model Hosts for Infectious Disease Research

  • Justin Glavis-Bloom
  • Maged Muhammed
  • Eleftherios Mylonakis
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 710)


The use of invertebrate model hosts has increased in popularity due to numerous advantages of invertebrates over mammalian models, including ethical, logistical and budgetary features. This review provides an introduction to three model hosts, the nematode Caenorhabditis elegans, the fruit fly Drosophila melanogaster and the larvae of Galleria mellonella, the greater wax moth. It highlights principal experimental advantages of each model, for C. elegans the ability to run high-throughput assays, for D. melanogaster the evolutionarily conserved innate immune response, and for G. mellonella the ability to conduct experiments at 37°C and easily inoculate a precise quantity of pathogen. It additionally discusses recent research that has been conducted with each host to identify pathogen virulence factors, study the immune response, and evaluate potential antimicrobial compounds, focusing principally on fungal pathogens.


Innate Immune Response Antifungal Compound Hyphal Formation Caffeic Acid Phenethyl Ester Model Host 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Alarco AM et al (2004) Immune-deficient Drosophila melanogaster: a model for the innate immune response to human fungal pathogens. J Immunol 172:5622–5628PubMedGoogle Scholar
  2. Apidianakis Y et al (2004) Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot Cell 3:413–419PubMedCrossRefGoogle Scholar
  3. Bazopoulou D, Tavernarakis N (2009) The NemaGENETAG initiative: large scale transposon insertion gene-tagging in Caenorhabditis elegans. Genetica 137:39–46PubMedCrossRefGoogle Scholar
  4. Begun J, Sifri CD, Goldman S, Calderwood SB, Ausubel FM (2005) Staphylococcus aureus virulence factors identified by using a high-throughput Caenorhabditis elegans-killing model. Infect Immun 73:872–877PubMedCrossRefGoogle Scholar
  5. Breger J et al (2007) Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 3:e18PubMedCrossRefGoogle Scholar
  6. Brennan M, Thomas DY, Whiteway M, Kavanagh K (2002) Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol 34:153–157PubMedCrossRefGoogle Scholar
  7. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77:71–94PubMedGoogle Scholar
  8. Chamilos G et al (2006) Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis 193:1014–1022PubMedCrossRefGoogle Scholar
  9. Coleman JJ et al (2010) Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol 5:321–332PubMedCrossRefGoogle Scholar
  10. Cotter G, Doyle S, Kavanagh K (2000) Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol 27:163–169PubMedCrossRefGoogle Scholar
  11. Cowen LE et al (2009) Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci USA 106:2818–2823PubMedCrossRefGoogle Scholar
  12. Diaz MH et al (2008) Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect Immun 76:4414–4421PubMedCrossRefGoogle Scholar
  13. Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11:30–36PubMedCrossRefGoogle Scholar
  14. Fire A et al (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811PubMedCrossRefGoogle Scholar
  15. Fuchs BB et al (2010) Role of filamentation in Galleria mellonella killing by Candida albicans. Microbes Infect 12:488–496PubMedCrossRefGoogle Scholar
  16. Garvis S et al (2009) Caenorhabditis elegans semi-automated liquid screen reveals a specialized role for the chemotaxis gene cheB2 in Pseudomonas aeruginosa virulence. PLoS Pathog 5:e1000540PubMedCrossRefGoogle Scholar
  17. Giacomotto J, Ségalat L (2010) High-throughput screening and small animal models, where are we? Br J Pharmacol 160:204–216PubMedCrossRefGoogle Scholar
  18. Hoffmann J (2003) The immune response of Drosophila. Nature 426:33–38PubMedCrossRefGoogle Scholar
  19. Kavanagh K, Fallon JP (2010) Galleria mellonella larvae as models for studying fungal virulence. Fungal Biol Rev 24:79–83CrossRefGoogle Scholar
  20. Kurz CL et al (2003) Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J 22:1451–1460PubMedCrossRefGoogle Scholar
  21. Lemaitre B (2004) The road to toll. Nat Rev Immunol 4:521–527PubMedCrossRefGoogle Scholar
  22. Lemaitre B, Hoffmann J (2007) The host defense of Drosophila melanogaster. Annu Rev Immunol 25:697–743PubMedCrossRefGoogle Scholar
  23. Lemaitre B, Reichhart JM, Hoffmann JA (1997) Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc Natl Acad Sci USA 23:14614–14619CrossRefGoogle Scholar
  24. Lindsay MA (2003) Target discovery. Nat Rev Drug Discov 2:831–838PubMedCrossRefGoogle Scholar
  25. Lionakis MS et al (2005) Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. J Infect Dis 191:1188–1195PubMedCrossRefGoogle Scholar
  26. Mahajan-Miklos S, Tan MW, Rahme LG, Ausubel FM (1999) Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96:47–56PubMedCrossRefGoogle Scholar
  27. Mowlds P, Kavanagh K (2008) Effect of pre-incubation temperature on susceptibility of Galleria mellonella larvae to infection by Candida albicans. Mycopathologia 165:5–12PubMedCrossRefGoogle Scholar
  28. Moy T et al (2009) High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol 4:527–533PubMedCrossRefGoogle Scholar
  29. Mueller NJ, Fishman JA (2003) Asymptomatic pulmonary cryptococcosis in solid organ transplantation: report of four cases and review of the literature. Transpl Infect Dis 5:140–143PubMedCrossRefGoogle Scholar
  30. Mylonakis E (2008) Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model host. Mycopathologia 165:1–3PubMedCrossRefGoogle Scholar
  31. Mylonakis E et al (2004) Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol Microbiol 54:407–419PubMedCrossRefGoogle Scholar
  32. Mylonakis E et al (2005) Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 73:3842–3850PubMedCrossRefGoogle Scholar
  33. O’Callaghan D, Vergunst A (2010) Non-mammalian animal models to study infectious disease: worms or fly fishing? Curr Opin Microbiol 13:79–85PubMedCrossRefGoogle Scholar
  34. Okoli I et al (2009) Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One 4:e7025PubMedCrossRefGoogle Scholar
  35. Pukkila-Worley R, Peleg A, Tampakakis E, Mylonakis E (2009) Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell 8:1750–1758PubMedCrossRefGoogle Scholar
  36. Riddle DL, Blumenthal T, Meyer BG, Priess JR (1997) C. elegans II, 2nd edn. Cold Spring Harbor Laboratory Press, PlainviewGoogle Scholar
  37. Rizki RM, Rizki TM (1984) Selective destruction of a host blood cell type by a parasitoid wasp. Proc Natl Acad Sci USA 81:6154–6158PubMedCrossRefGoogle Scholar
  38. Rowan R, Moran C, McCann M, Kavanagh K (2009) Use of Galleria mellonella larvae to evaluate the in vivo anti-fungal activity of [Ag2(mal)(phen)3]. Biometals 22:461–467PubMedCrossRefGoogle Scholar
  39. Sekiya M et al (2008) A cyclopentanediol analogue selectively suppresses the conserved innate immunity pathways, Drosophila IMD and TNF-alpha pathways. Biochem Pharmacol 75:2165–2174PubMedCrossRefGoogle Scholar
  40. Spring DR (2005) Chemical genetics to chemical genomics: small molecules offer big insights. Chem Soc Rev 34:472–482PubMedCrossRefGoogle Scholar
  41. Tan MW, Rahme LG, Sternberg JA, Tompkins RG, Ausubel FM (1999) Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc Natl Acad Sci USA 96:2408–2413PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Justin Glavis-Bloom
    • 1
  • Maged Muhammed
    • 1
  • Eleftherios Mylonakis
    • 2
  1. 1.Division of Infectious DiseasesMassachusetts General HospitalBostonUSA
  2. 2.Harvard Medical School, Division of Infectious DiseaseMassachusetts General HospitalBostonUSA

Personalised recommendations